SCHEDULE 13G/A: BlackRock Amends Guardian Pharmacy Stake Disclosure
Schedule 13G Amendment
BlackRock, Inc. filed an amended Schedule 13G disclosing its beneficial ownership of 4.2% of Guardian Pharmacy Services, Inc. Class A Stock as of December 31, 2025.
Summary
- BlackRock, Inc. reported beneficial ownership of 1,507,822 shares of Guardian Pharmacy Services, Inc. Class A Stock.
- This represents 4.2% of the Class A Stock outstanding.
- BlackRock, Inc. holds sole voting power over 1,473,050 shares and sole dispositive power over 1,507,822 shares.
- The filing is an Amendment No. 1 to a previous Schedule 13G.
- One of BlackRock's subsidiaries, BlackRock Investment Management, LLC, beneficially owns 5% or greater of the outstanding shares of Guardian Pharmacy Services, Inc. Class A Stock, as noted in the Item 7 exhibit.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of passive beneficial ownership by a large institutional investor, BlackRock, Inc. It provides factual information without expressing positive or negative sentiment regarding the issuer's performance or outlook.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding Guardian Pharmacy Services, Inc.'s future performance or BlackRock's investment strategy beyond the current ownership disclosure.
Management Comments
- BlackRock, Inc. certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Industry Context
This filing represents a routine disclosure by a major institutional asset manager, BlackRock, Inc., regarding its passive investment in Guardian Pharmacy Services, Inc. Such disclosures are common for large funds that hold significant, but non-controlling, stakes in publicly traded companies, reflecting standard portfolio management activities.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Update | BlackRock, Inc. executed a new Power of Attorney, effective January 21, 2025, revoking a previous one dated April 30, 2023. This document authorizes specific individuals to execute SEC filings on behalf of BlackRock and its subsidiaries. | 01/21/2025 | This is an internal corporate governance update for BlackRock, Inc. to streamline its SEC filing processes, not a change in Guardian Pharmacy Services, Inc.'s governance. |
Stakeholder Impact
- Shareholders: BlackRock's continued passive ownership indicates a stable institutional presence, but the filing itself does not suggest any immediate strategic shifts or significant impact on other shareholders beyond the disclosure of its stake.
- Management: The filing confirms BlackRock's passive investment intent, indicating no immediate plans to influence the control or management of Guardian Pharmacy Services, Inc.
Key Dates
| Date | Description |
|---|---|
| 04/30/2023 | Date of previous Power of Attorney revoked by the new one. |
| 01/21/2025 | Date of execution for the new Power of Attorney by BlackRock, Inc. |
| 12/31/2025 | Date of the event which requires the filing of this statement, representing the ownership snapshot. |
| 01/21/2026 | Signature date of the Schedule 13G filing. |
Keywords
BlackRock, Guardian Pharmacy Services, Schedule 13G, Beneficial Ownership, Institutional Investor, Class A Stock, Equity Holding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.